NOT-DA-26-015: Notice of Early Expiration of PAR-25-204, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

Notice of Early Expiration of PAR-25-204, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

Notice Number:

NOT-DA-26-015

Key Dates

Release Date:

August 06, 2026

Related Announcements

November 18, 2024 - NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed). See NOFO PAR-25-204

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to alert applicants of the early expiration of PAR-25-204, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)". The Notice of Funding Opportunity (NOFO), PAR-25-204, will be expired early on August 13, 2026. No further applications will be accepted for consideration under this NOFO. Applicants are encouraged to consider applying for the following NOFOs:

PA-27-034 - NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)

PA-27-035 - NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)

PA-27-036 - NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)

Inquiries

Please direct all inquiries to:

Office of Research Training and Career Development
National Institutes of Drug Abuse (NIDA)
Email: [email protected]